Fact based stock research
C.R. Bard (NYSE:BCR)




Research has been discontinued. Contact us if you want research on this stock.



C.R. Bard stock research in summary

crbard.com


C.R. Bard shares have a HOLD rating. They show above average growth and are safely financed, but are bad value. We recommend holding C.R. Bard shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Equipment
Index
Size class Medium

December 8, 2017. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()




Research History: C.R. Bard

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
1
10
15
15
STOCK GROWTH RANKS
55
62
89
89
STOCK SAFETY RANKS
50
56
53
53
COMBINED STOCK RANKS
21
19
50
50

Last update of Combined Rank: 8-Dec-2017. Stock research history is based on the Obermatt Method. The higher the rank, the better is C.R. Bard in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 8-Dec-2017. Stock analysis on value ratios: The higher the rank, the lower the value ratio of C.R. Bard; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
36
53
50
50
PROFIT GROWTH
44
44
44
83
STOCK RETURNS
62
73
90
90
CONSOLIDATED RANK: GROWTH
55
62
89
89

Financial reporting date of Growth Rank: 30-Sep-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of C.R. Bard.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
71
70
76
77
REFINANCING
1
10
13
13
LIQUIDITY
77
81
73
74
CONSOLIDATED RANK: SAFETY
50
56
53
53

Financial reporting date of Safety Rank: 30-Sep-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of C.R. Bard and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for C.R. Bard from December 8, 2017.